Literature DB >> 11420197

99mTc-HMPAO leucocyte scintigraphy fails to detect Crohn's disease in the proximal gastrointestinal tract.

S M Davison1, S Chapman, M S Murphy.   

Abstract

OBJECTIVE: To investigate the use of (99m)Tc-HMPAO (hexamethyl propylene amine oxime) leucocyte scintigraphy as a non-invasive screening test for inflammatory bowel disease. PATIENTS: 10 children with suspected Crohn's disease, in whom routine investigation using barium contrast radiology, upper gastrointestinal endoscopy, colonoscopy, and mucosal biopsies had identified severe gastroduodenal and/or jejunal involvement.
DESIGN: (99m)Tc-HMPAO leucocyte scintigraphic studies performed in each of these cases were assessed by a radiologist who was blinded to the disease distribution.
RESULTS: In nine cases there was no scintigraphic evidence of inflammation in the proximal gastrointestinal tract. The 10th child had both gastroduodenal and jejunal involvement, but scintigraphy only revealed faint jejunal positivity.
CONCLUSIONS: (99m)Tc-HMPAO leucocyte scintigraphy should not be depended upon as a screening test for Crohn's disease. False negative results are likely in cases with Crohn's disease confined to the proximal gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420197      PMCID: PMC1718846          DOI: 10.1136/adc.85.1.43

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  Leucocyte scintigraphy to localize inflammatory activity in ulcerative colitis and Crohn's disease.

Authors:  M Vilien; S L Nielsen; M Jørgensen; V Binder; K Hvid-Jacobsen; D Berild; H Kelbaek
Journal:  Scand J Gastroenterol       Date:  1992-07       Impact factor: 2.423

2.  Colonoscopy and technetium-99m white cell scan in children with suspected inflammatory bowel disease.

Authors:  S Cucchiara; L Celentano; T M de Magistris; A Montisci; V D Iula; S Fecarotta
Journal:  J Pediatr       Date:  1999-12       Impact factor: 4.406

3.  Gastric and small bowel Crohn's disease assessed with leukocytes-Tc(99m) scintigraphy.

Authors:  M Charron; C Di Lorenzo; S Kocoshis
Journal:  Pediatr Surg Int       Date:  1999       Impact factor: 1.827

4.  Clinical features of gastroduodenal Crohn's disease in adolescents.

Authors:  A M Griffiths; E Alemayehu; P Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-02       Impact factor: 2.839

5.  Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis?

Authors:  S Almer; L Franzén; A M Peters; M Tjädermo; S Ekberg; G Granerus; M Ström
Journal:  Scand J Gastroenterol       Date:  1992-12       Impact factor: 2.423

6.  Tc HMPAO-labelled white cell scintigraphy in Cröhn's disease of the small bowel.

Authors:  N Kennan; M Hayward
Journal:  Clin Radiol       Date:  1992-05       Impact factor: 2.350

7.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; E Schmidt; C Schümichen; P Billmann; H Schmidt; W Gerok
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

8.  99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.

Authors:  A M Peters; M E Roddie; H J Danpure; S Osman; G P Zacharopoulos; P George; A W Stuttle; J P Lavender
Journal:  Nucl Med Commun       Date:  1988-06       Impact factor: 1.690

9.  Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes.

Authors:  M Charron; S R Orenstein; S Bhargava
Journal:  J Nucl Med       Date:  1994-03       Impact factor: 10.057

10.  Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.

Authors:  G Sciarretta; A Furno; M Mazzoni; C Basile; P Malaguti
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

View more
  3 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 2.  Inflammatory bowel disease.

Authors:  R M Beattie; N M Croft; J M Fell; N A Afzal; R B Heuschkel
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

3.  Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.

Authors:  Federico Caobelli; Laura Evangelista; Natale Quartuccio; Demetrio Familiari; Corinna Altini; Angelo Castello; Mariapaola Cucinotta; Rossella Di Dato; Cristina Ferrari; Aurora Kokomani; Iashar Laghai; Riccardo Laudicella; Silvia Migliari; Federica Orsini; Salvatore Antonio Pignata; Cristina Popescu; Erinda Puta; Martina Ricci; Silvia Seghezzi; Alessandro Sindoni; Martina Sollini; Letterio Sturiale; Anna Svyridenka; Vittoria Vergura; Pierpaolo Alongi
Journal:  World J Radiol       Date:  2016-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.